Naltrexone/bupropion vs placebo
Cardiovascular morbidity · Men and non‐pregnant women ≥ 18 years old with essential hypertension
Naltrexone/bupropion showed no clear difference in cardiovascular morbidity compared with placebo (low certainty).
1 finding from 1 review
- Long‐term effects of weight‐reducing drugs in people with hypertension 2021 · Cochrane Headline outcomes onlyRR 1.11 [0.87, 1.41]1 study · 8283 participantsLow